Inventor · disambiguated record
Yasutaka Hoashi
Also filed as: HOASHI YASUTAKA
27 granted patents·7 pending applications·74 citations·filing 2007–2025
95Inventor score
Files withTAKEDA PHARMACEUTICALS CO22TAKEDA PHARMACEUTICAL5KOIKE TATSUKI3UCHIKAWA OSAMU3ASO KAZUYOSHI1
Top patents by PatentIndex Score
34 records- 0197US10428023B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 1, 2019·22 cites·1 claims
- 0296US10584097B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Mar 10, 2020·14 cites·1 claims
- 0395US11028048B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 8, 2021·8 cites·9 claims
- 0494US11440883B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 13, 2022·3 cites·1 claims
- 0589US11993570B2Cationic lipidsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted May 28, 2024·1 cites·8 claims
- 0688US11987586B1Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonistsTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted May 21, 2024·1 cites·16 claims
- 0787US11319286B2Heterocyclic compound and application thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted May 3, 2022·4 cites·10 claims
- 0886US2024360080A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0984US11655241B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted May 23, 2023·2 cites·15 claims
- 1083US8030337B2Tricyclic compound and pharmaceutical use thereofTAKEDA PHARMACEUTICAL·Filed 2007·Granted Oct 4, 2011·4 cites·3 claims
- 1181US8236837B2Tricyclic compound and pharmaceutical use thereofUCHIKAWA OSAMU·Filed 2011·Granted Aug 7, 2012·4 cites·3 claims
- 1280US12421188B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 23, 2025·0 cites·19 claims
- 1380US12415782B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 16, 2025·0 cites·19 claims
- 1480US12404237B2Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivativesTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 2, 2025·0 cites·19 claims
- 1577US8349879B2Tricyclic compound and pharmaceutical use thereofTAKEDA PHARMACEUTICAL·Filed 2011·Granted Jan 8, 2013·2 cites·3 claims
- 1676US8552037B2Tricyclic compound and pharmaceutical use thereofTAKEDA PHARMACEUTICAL·Filed 2012·Granted Oct 8, 2013·2 cites·17 claims
- 1776US2023063805A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1875US2021276949A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1973US8273761B2Tricyclic compound and medical use thereofUCHIKAWA OSAMU·Filed 2007·Granted Sep 25, 2012·2 cites·10 claims
- 2073US8247429B2Tricyclic compound and pharmaceutical use thereofUCHIKAWA OSAMU·Filed 2007·Granted Aug 21, 2012·2 cites·10 claims
- 2172US8110585B2Bicyclic compound and pharmaceutical use thereofKOIKE TATSUKI·Filed 2008·Granted Feb 7, 2012·2 cites·17 claims
- 2268US10252974B2Cationic lipidTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Apr 9, 2019·1 cites·8 claims
- 2363US8895591B2Tricyclic compound and pharmaceutical use thereofTAKEDA PHARMACEUTICAL·Filed 2013·Granted Nov 25, 2014·0 cites·12 claims
- 2463US2025197343A1Cationic lipidTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2560US8785460B2Tricyclic compounds and use thereofASO KAZUYOSHI·Filed 2009·Granted Jul 22, 2014·0 cites·13 claims
- 2657US2014350260A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICAL·Filed 2014·Application pending·0 cites
- 2755US2025250230A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2853US12077522B2Heterocyclic compound and application thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 3, 2024·0 cites·11 claims
- 2952US12091410B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 17, 2024·0 cites·13 claims
- 3052US8822699B2Heterocyclic compound and use thereofKOIKE TATSUKI·Filed 2011·Granted Sep 2, 2014·0 cites·6 claims
- 3151US12448377B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Oct 21, 2025·0 cites·16 claims
- 3251US12071434B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Aug 27, 2024·0 cites·14 claims
- 3347US12479791B2Cationic lipidTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Nov 25, 2025·0 cites·10 claims
- 3434US2012142672A1Heterocyclic compound and use thereofKOIKE TATSUKI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yasutaka Hoashi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →